Human Syndecan-1 / SDC1 / CD138 Protein (ECD, His Tag) 11429-H08H from Sino Biological, Inc. | Biocompare.com

Supplier Images

Human Syndecan-1 / SDC1 / CD138 Protein (ECD, His Tag)

Human Syndecan-1 / SDC1 / CD138 Protein (ECD, His Tag)

Be the first to write a review!

Citations:

Supplier Page from
Sino Biological, Inc. for
Human Syndecan-1 / SDC1 / CD138 Protein (ECD, His Tag)

Description

A DNA sequence encoding the human SDC1 (NP_002988.3) extracellular domain (Met 1-Glu 251) was expressed, with a polyhistidine tag at the C-terminus

Product Specs
ItemHuman Syndecan-1 / SDC1 / CD138 Protein (ECD, His Tag)
CompanySino Biological, Inc.
Price Supplier Page View Company Product Page
Catalog Number11429-H08H
Conjugate/TagC-His
Purity≥ 92 % as determined by SDS-PAGE. ≥ 95 % as determined by SEC-HPLC
TypeRecombinant protein
Molecular WeightThe recombinant human SDC1 consists of 245 amino acids and predictes a molecular mass of 25.6 kDa. In SDS-PAGE under reducing conditions, the apparent molecular mass of rh SDC1 is approximately 48-55 kDa due to glycosylation
SpeciesHuman
Molecule NameSDC1
Source/Expression SystemHEK293 Cells
NCBI Full Gene Namesyndecan 1
NCBI Gene AliasesCD138, SDC, SYND1, syndecan
FormatLyophilized from sterile PBS, pH 7.4

Add to Compare List

Sino Biological, Inc.

Sino Biological, Inc.

1400 Liberty Ridge Drive

Suite 101

Wayne, PA 19087

United States

Phone: 215-583-7898
Fax: 267-657-0217

Email: marketing@sinobiological.com

Company Profile

Website: http://www.sinobiological.com/

(1) Prolonged Cardiopulmonary Bypass is Associated With Endothelial Glycocalyx DegradationThe Journal of surgical researchJuly 1, 2020Robich M, Ryzhov S, Kacer D, Palmeri M, Peterson SM, Quinn RD, Carter D, Sheppard F, Hayes T, Sawyer DB, et al.

(2) Juxtacrine Signaling Inhibits Antitumor Immunity by Upregulating PD-L1 ExpressionCancer researchJuly 15, 2018Yang WH, Cha JH, Xia W, Lee HH, Chan LC, Wang YN, Hsu JL, Ren G, Hung MC.

(3) Anti-human CD138 monoclonal antibodies and their bispecific formats: generation and characterizationImmunopharmacology and immunotoxicologyJune 1, 2016Chen D, Zou J, Zong Y, Meng H, An G, Yang L.

(4) Immunotherapy based on bispecific T-cell engager with hIgG1 Fc sequence as a new therapeutic strategy in multiple myelomaCancer scienceMay 1, 2015Zou J, Chen D, Zong Y, Ye S, Tang J, Meng H, An G, Zhang X, Yang L.

Be the First to Write a Review!